Dendritic cell-CEA peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-012965
A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of carcinoembryonic antigen (CEA), a tumor-associated antigen expressed by a wide range of cancers. When the altered dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing CEA.
| Identifier | MLC-T-ONC-012965 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CEA peptide-pulsed DC vaccine; CEA peptide-pulsed dendritic cell vaccine; Dendritic cell-carcinoembryonic antigen peptide vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012965",
"term": "Dendritic cell-CEA peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of carcinoembryonic antigen (CEA), a tumor-associated antigen expressed by a wide range of cancers. When the altered dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing CEA.",
"synonyms": [
"CEA peptide-pulsed DC vaccine",
"CEA peptide-pulsed dendritic cell vaccine",
"Dendritic cell-carcinoembryonic antigen peptide vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dendritic-cell-cea-peptide-vaccine/"
}
Record 5,808 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.